Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**paracetamol + carisoprodol + caffeine** is an oral pharmaceutical combination used for the short-term management of musculoskeletal pain, muscle spasms, headaches, migraines, rheumatic pain, backache, and menstrual pain. \n- **Carisoprodol** is a centrally acting skeletal muscle relaxant that inhibits multisynaptic reflex pathways in the brain and spinal cord, leading to relief of muscle spasms.\n- **Paracetamol** (acetaminophen) is an analgesic and antipyretic that reduces pain and fever by inhibiting the synthesis of prostaglandins in the brain.\n- **Caffeine** is a methylxanthine CNS stimulant that boosts the analgesic effects of paracetamol and counteracts the sedative effect of carisoprodol, improving alertness.\nThis combination may be used for conditions including acute musculoskeletal injuries, tension headaches, and fibromyalgia. It is generally prescribed for short durations due to the habit-forming potential of carisoprodol. \nPatients should avoid additional sources of paracetamol or caffeine and consult their healthcare provider regarding safety in pregnancy, breastfeeding, and the risk of drowsiness. \nThe efficacy of this combination in fibromyalgia has also been demonstrated in clinical trials[1][2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on paracetamol + carisoprodol + caffeine.